Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001640334-20-000639
Filing Date
2020-03-27
Accepted
2020-03-27 14:58:21
Documents
45
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K acbm_10k.htm 10-KT 550115
2 CERTIFICATION acbm_ex311.htm EX-31.1 8548
3 CERTIFICATION acbm_ex321.htm EX-32.1 3534
  Complete submission text file 0001640334-20-000639.txt   2393071

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT acbm-20191231.xml EX-101.INS 414730
5 XBRL TAXONOMY EXTENSION SCHEMA acbm-20191231.xsd EX-101.SCH 27862
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acbm-20191231_cal.xml EX-101.CAL 26316
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acbm-20191231_def.xml EX-101.DEF 47817
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE acbm-20191231_lab.xml EX-101.LAB 271101
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acbm-20191231_pre.xml EX-101.PRE 135173
Mailing Address 12175 VISIONARY WAY SUITE 1160 FISHERS IN 46038
Business Address 12175 VISIONARY WAY SUITE 1160 FISHERS IN 46038 (317) 286-6788
ACRO BIOMEDICAL CO., LTD. (Filer) CIK: 0001622996 (see all company filings)

EIN.: 471950356 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-KT | Act: 34 | File No.: 333-207765 | Film No.: 20751028
SIC: 7900 Services-Amusement & Recreation Services